查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1722789

單純皰疹病毒治療市場報告：規模、佔有率、趨勢及預測（按類型、藥物類型、給藥途徑、配銷通路和地區），2025 年至 2033 年

Herpes Simplex Virus Treatment Market Report Size, Share, Trends and Forecast by Type, Drug Type, Route of Administration, Distribution Channel, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 134 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球單純皰疹病毒治療市場規模價值 27 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 40 億美元，2025-2033 年期間的複合年成長率為 4.51%。北美目前佔據市場主導地位。人們對各種 HSV 藥物的認知不斷提高、醫療保健支出不斷增加以及透過線上和線下藥局廣泛提供 HSV 藥物是推動市場發展的一些關鍵因素。

單純皰疹病毒 (HSV) 是一種傳染性病毒感染，透過唾液、精液和陰道分泌物傳播，並引起水皰和潰瘍。它在個體之間產生單純皰疹病毒-1（HSV-1）感染和單純皰疹病毒-2（HSV-2）感染。它也會在出現瘡之前引起發燒、身體疼痛、淋巴結腫大、頭痛、刺痛、搔癢或口腔周圍灼熱感。此病通常發生在性伴侶患有 HSV 或免疫功能低下的人群中。可以透過服用一些抗病毒藥物（例如阿昔洛韋、泛昔洛韋和伐昔洛韋）來治癒 HSV。也可以透過一些家庭療法來治療，例如熱敷或冷敷、蘆薈、小蘇打或玉米澱粉和水的糊狀物以及壓碎的大蒜混合物。 HSV 治療有助於降低病毒傳播的機會並減少疫情爆發的頻率或嚴重程度。

單純皰疹病毒治療市場趨勢：

目前，全球性傳播感染（STI）的盛行率不斷上升是支撐市場成長的關鍵因素之一。此外，由於全球人們對性健康的擔憂，對 HSV 治療的需求不斷增加，這也推動了市場的成長。除此之外，由於全球人們對 HSV 感染風險和併發症的認知不斷提高，對 HSV 治療的需求不斷成長，這對市場產生了積極影響。此外，對副作用較小、療效較高的新型 HSV 治療方案的需求不斷成長，也推動了市場的成長。除此之外，醫療保健支出的增加以及個人收入水準的提高，為行業投資者提供了豐厚的成長機會。此外，全球線上和線下藥局廣泛提供 HSV 藥物，這也推動了市場的成長。除此之外，人們對 HSV 治療方案的需求不斷增加，以預防嚴重的併發症，如腦炎（腦部感染）或角膜炎（眼部感染），這也促進了市場的成長。此外，HSV 治療方案的不斷創新和各種藥物的批准正在加強市場的成長。

本報告回答的關鍵問題

  • 單純皰疹病毒治療市場有多大？單純皰疹病毒治療市場的未來前景如何？
  • 推動單純皰疹病毒治療市場的關鍵因素有哪些？
  • 哪個地區佔單純皰疹病毒治療市場的最大佔有率？
  • 全球單純皰疹病毒治療市場領先的公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球單純皰疹病毒治療市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 單純皰疹病毒-1感染
  • 單純皰疹病毒第二型感染
  • 其他

第7章：市場區隔：依藥物類型

  • 阿昔洛韋
  • 伐昔洛韋
  • 泛昔洛韋
  • 其他

第8章：市場區隔：依行政途徑

  • 口服
  • 注射劑
  • 外用

第9章：市場區隔：按配銷通路

  • 醫院藥房
  • 藥局
  • 零售店
  • 網路藥局

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agenus Inc.
    • Apotex Inc.
    • Avet Pharmaceuticals Inc.
    • Carlsbad Tech
    • EPI Health LLC
    • F. Hoffmann-La Roche Ltd
    • Fresenius SE & Co. KGaA
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals Limited
    • Merck & Co. Inc.
    • Novartis AG
    • Sanofi SA
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
Product Code: SR112025A5257

The global herpes simplex virus treatment market size was valued at USD 2.7 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 4.0 Billion by 2033, exhibiting a CAGR of 4.51% during 2025-2033. North America currently dominates the market. The growing awareness among individuals about various medications of HSV, increasing healthcare expenditure, and wide availability of HSV medications through online and offline pharmacy stores represent some of the key factors driving the market.

Herpes simplex virus (HSV) refers to a contagious viral infection that is spread through saliva, semen, and vaginal secretion and causes blisters and ulcers. It produces herpes simplex virus-1 (HSV-1) infection and herpes simplex virus-2 (HSV-2) infection among individuals. It also causes fever, body aches, swollen lymph nodes, headache, tingling, itching, or burning sensation around the mouth of an individual before the appearance of sores. It usually occurs among people having a sexual partner with HSV or who are immunocompromised. HSV can be cured by consuming some antiviral medications, such as acyclovir, famciclovir, and valacyclovir. It can also be treated through some home remedies, such as a warm or cold compress, aloe vera, a paste of baking soda or cornstarch and water, and a mixture of crushed garlic. HSV treatment can aid in lowering the chance of transmitting the virus and reducing the frequency or severity of outbreaks.

Herpes Simplex Virus Treatment Market Trends:

At present, the rising prevalence of sexually transmitted infections (STIs) among the masses around the world represents one of the key factors supporting the growth of the market. In addition, the increasing demand for HSV treatments due to concerns about sexual health among individuals worldwide is bolstering the growth of the market. Besides this, the growing demand for HSV treatments due to the increasing awareness among individuals about the risks and complications of HSV infection across the globe is positively influencing the market. Moreover, the rising demand for new HSV treatment options with reduced side effects and enhanced effectiveness is propelling the growth of the market. Apart from this, the increasing healthcare expenditure, along with the inflating income level of individuals, is offering lucrative growth opportunities to industry investors. Additionally, the wide availability of HSV medications through online and offline pharmacy stores across the globe is impelling the growth of the market. Besides this, the increasing demand for HSV treatment options to prevent severe complications, such as encephalitis (brain infection) or keratitis (eye infection) among individuals, is contributing to the growth of the market. Furthermore, the rising innovations in HSV treatment options and various drug approvals are strengthening the growth of the market.

Key Market Segmentation:

Type Insights:

  • Herpes Simples Virus-1 Infection
  • Herpes Simplex Virus-2 Infection
  • Others

Drug Type Insights:

  • Acyclovir
  • Valacyclovir
  • Famciclovir
  • Others

Route of Administration Insights:

  • Oral
  • Injectable
  • Topical

Distribution Channel Insights:

  • Hospital Pharmacy
  • Drug Stores
  • Retail Stores
  • Online Pharmacy

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for herpes simplex virus treatment. Some of the factors driving the North America herpes simplex virus treatment market included the growing prevalence of HSV infection among individuals, increasing number of clinical trials for its treatment, rising awareness about various medications of HSV, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global herpes simplex virus treatment market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Agenus Inc., Apotex Inc., Avet Pharmaceuticals Inc., Carlsbad Tech, EPI Health LLC, F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Merck & Co. Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.How big is the herpes simplex virus treatment market?
  • 2.What is the future outlook of the herpes simplex virus treatment market?
  • 3.What are the key factors driving the herpes simplex virus treatment market?
  • 4.Which region accounts for the largest herpes simplex virus treatment market share?
  • 5.Which are the leading companies in the global herpes simplex virus treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Herpes Simplex Virus Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Herpes Simples Virus-1 Infection
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Herpes Simplex Virus-2 Infection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Acyclovir
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Valacyclovir
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Famciclovir
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Injectable
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Drug Stores
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Retail Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Online Pharmacy
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agenus Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Apotex Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Avet Pharmaceuticals Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Carlsbad Tech
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 EPI Health LLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 F. Hoffmann-La Roche Ltd
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Fresenius SE & Co. KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 GlaxoSmithKline plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Glenmark Pharmaceuticals Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Merck & Co. Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Novartis AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Sanofi S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Teva Pharmaceutical Industries Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Viatris Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials

List of Figures

  • Figure 1: Global: Herpes Simplex Virus Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Herpes Simplex Virus Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Herpes Simplex Virus Treatment Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Herpes Simplex Virus Treatment Market: Breakup by Drug Type (in %), 2024
  • Figure 6: Global: Herpes Simplex Virus Treatment Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Herpes Simplex Virus Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Herpes Simplex Virus Treatment Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Herpes Simplex Virus Treatment (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Herpes Simplex Virus Treatment (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Herpes Simplex Virus Treatment (Acyclovir) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Herpes Simplex Virus Treatment (Acyclovir) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Herpes Simplex Virus Treatment (Famciclovir) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Herpes Simplex Virus Treatment (Famciclovir) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Herpes Simplex Virus Treatment (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Herpes Simplex Virus Treatment (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Herpes Simplex Virus Treatment (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Herpes Simplex Virus Treatment (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Herpes Simplex Virus Treatment (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Herpes Simplex Virus Treatment (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Herpes Simplex Virus Treatment (Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Herpes Simplex Virus Treatment (Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Herpes Simplex Virus Treatment (Retail Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Herpes Simplex Virus Treatment (Retail Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia-Pacific: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia-Pacific: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Herpes Simplex Virus Treatment Market: Breakup by Country (in %), 2024
  • Figure 85: Middle East and Africa: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Global: Herpes Simplex Virus Treatment Industry: SWOT Analysis
  • Figure 87: Global: Herpes Simplex Virus Treatment Industry: Value Chain Analysis
  • Figure 88: Global: Herpes Simplex Virus Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Herpes Simplex Virus Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 4: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 5: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Herpes Simplex Virus Treatment Market: Competitive Structure
  • Table 8: Global: Herpes Simplex Virus Treatment Market: Key Players